tiprankstipranks
Abliva (NEVPF)
OTHER OTC:NEVPF

Abliva (NEVPF) Stock Price & Analysis

4 Followers

NEVPF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.02
Previous Close$0.01
Volume204.00
Average Volume (3M)204.00
Market Cap
$15.97M
Enterprise Value$48.47M
Total Cash (Recent Filing)kr0.00
Total Debt (Recent Filing)kr32.50M
Price to Earnings (P/E)-1.2
Beta1790.52
May 21, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,056,299,165
10 Day Avg. Volume0
30 Day Avg. Volume204
Standard Deviation1601.13
R-Squared0.05
Alpha136.41
Financial Highlights & Ratios
Price to Book (P/B)1.69
Price to Sales (P/S)340.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

NEVPF FAQ

What was Abliva’s price range in the past 12 months?
Abliva lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.
    What is Abliva’s market cap?
    Currently, no data Available
    When is Abliva’s upcoming earnings report date?
    Abliva’s upcoming earnings report date is May 21, 2024 which is in 20 days.
      How were Abliva’s earnings last quarter?
      Abliva released its earnings results on Feb 23, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
        Is Abliva overvalued?
        According to Wall Street analysts Abliva’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Abliva pay dividends?
          Abliva does not currently pay dividends.
          What is Abliva’s EPS estimate?
          Abliva’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Abliva have?
          Abliva has 1,056,299,200 shares outstanding.
            What happened to Abliva’s price movement after its last earnings report?
            Abliva reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Abliva?
              Currently, no hedge funds are holding shares in NEVPF
              ---

              Abliva Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Fundamentals

              Return on Equity
              -78.73%
              Trailing 12-Months
              Asset Growth
              -50.79%
              Trailing 12-Months

              Company Description

              Abliva

              NeuroVive Pharmaceutical AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Novo Nordisk
              BeiGene
              Alnylam Pharma
              Sarepta Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis